Mitoxantrone
规格
65271-80-9CAS 号
833-758-3EC 号
1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dioneIUPAC 名称
C22H28N4O6化学式
444.5 g/mol分子量
mitoxantrone; 65271-80-9; Mitozantrone; Mitoxanthrone; DHAQ; Mitoxantron; Mitoxantrona; Mitoxantronum; Misostol; NSC-279836; NSC 279836; BZ114NVM5P; NSC279836; 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; DTXSID4046947; CHEBI:50729; Ralenova; NSC299195; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-; Acetate, Mitoxantrone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-; 1,4-DIHYDROXY-5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-9,10-ANTHRACENEDIONE; 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9,10-dihydroanthracene-9,10-dione; dihydroxyanthracenedione; RefChem:55656; mitoyantrone hydrochloride; DTXCID2026947; L01DB07; NSC301739D; NSC 301739D; NSC287836; NSC 287836; CL232325; CL 232325; 1,3-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthracenedione; 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthroquinone; 833-758-3; Dihydroxyanthraquinone; Mitoxantrone [INN]; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; DHAD; MFCD00242942; C22H28N4O6; Mitoxantrone (INN); 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; MLS002703044; 1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione; 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione; Mitoxantronum [INN-Latin]; Mitoxantrona [INN-Spanish]; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione; ANTHRAQUINONE, 5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-1,4-DIHYDROXY-; MIX; MLS001333711; Misostol (TN); CCRIS 7604; Mitoxantrone free base; NCGC00015693-02; Mitoxantrone (free base); SMR000058480; Mitoxantrone [INN:BAN]; CAS-70476-82-3; UNII-BZ114NVM5P; DHAQ (*Diacetate salt*); BRN 2795126; SR-01000076001; Mitoxantrone base; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 2fum; 65271-80-9 (free base); Immunex (Salt/Mix); Spectrum_001655; Mitoxantrone (Standard); CHEMBL58; Prestwick0_000385; Prestwick1_000385; Prestwick2_000385; Prestwick3_000385; Spectrum2_000908; Spectrum3_001590; Spectrum4_000866; Spectrum5_001205; Lopac-M-6545; MITOXANTRONE [MI]; MITOXANTRONE [IARC]; cid_4212; Neuro_000153; SCHEMBL3000; MITOXANTRONE [VANDF]; BIDD:PXR0181; Lopac0_000779; BSPBio_000569; BSPBio_003160; KBioGR_001531; KBioSS_002135; DivK1c_000516; MITOXANTRONE [WHO-DD]; SPBio_000756; SPBio_002490; BPBio1_000627; GTPL7242; orb1221914; orb1300634; SCHEMBL29353270; SCHEMBL29720597; BDBM67690; cid_5458171; KBio1_000516; KBio2_002135; KBio2_004703; KBio2_007271; KBio3_002660; NINDS_000516; GLXC-03038; HMS2090D05; HMS3655E20; KUC108634N; CCG-36371; EBC-17113; HY-13502R; s1889; STK631833; Mitoxantrone hydrochloride (Salt/Mix); AKOS005564036; DB01204; FD26022; KSC-19-204; SDCCGSBI-0050757.P004; 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-anthracene-9,10-dione; IDI1_000516; SMP2_000179; NCGC00015693-01; NCGC00015693-03; NCGC00015693-04; NCGC00015693-05; NCGC00015693-06; NCGC00015693-08; NCGC00015693-13; NCGC00015693-21; NCGC00015693-23; NCGC00162251-01; AC-37649; AS-35321; HY-13502; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; NCI60_002276; NCI60_002535; SMR001549953; SY226320; SBI-0050757.P003; AB00053716; M3133; NS00008439; SW196745-6; T6588; VU0244399-2; D08224; EN300-117257; AB00053716-18; AB00053716-19; AB00053716-22; AB00053716_23; AB00053716_24; F801706; Q239426; SR-01000076001-7; BRD-K21680192-001-01-5; BRD-K21680192-001-11-4; BRD-K21680192-300-05-2; BRD-K21680192-300-07-8; BRD-K21680192-300-09-4; BRD-K21680192-300-10-2; BRD-K21680192-300-12-8; BRD-K21680192-300-14-4; BRD-K21680192-300-15-1; BRD-K21680192-300-16-9; 1,4-bis[2-(2-hydroxyethylamino)-ethylamino]-5,8-dihydroxyanthraquinone; 1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-dihydroxyanthraquinone; 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone; 9, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl] amino]-; 1,4-Dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone; 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone;hydrochloride; 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;hydrochloride; 1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione;hydrochloride; MITOXANTRONE; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE同义词
